Literature DB >> 15998834

An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes.

Yves Renaudineau1, Sophie Hillion, Alain Saraux, Rizgar A Mageed, Pierre Youinou.   

Abstract

T lymphocytes and a subpopulation of B lymphocytes express the CD5 coreceptor. Its functional importance is evident from the multiple levels and developmental stages of the regulation of its expression. We here report the discovery of a novel regulatory exon upstream of the noncoding region of the CD5 gene in humans. This alternate exon 1 is designated E1B (with the conventional exon 1 renamed E1A) and was shown to regulate the expression of CD5. E1B-containing transcripts existed exclusively in B lymphocytes and encoded a protein that was truncated and retained intracellularly. As a consequence, the amount of E1A-containing transcripts was down-regulated and the membrane CD5 expression was diminished in the presence of E1B-containing transcripts. High levels of E1A transcripts were found in chronic lymphocytic leukemia, and there were no E1A transcripts in 697 pre-B cells, which have no membrane CD5. Introduction of E1B into Jurkat cells reduced their membrane expression of CD5, and sequence analysis revealed that the E1B motif is a defective human endogenous retrovirus. A balance between the 2 alternative exons 1 might be central to the regulation of membrane CD5 in human B cells, and, through CD5-associated SH2-containing phosphatase 1, to the modulation of B-cell antigen receptor-transduced signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998834     DOI: 10.1182/blood-2005-02-0597

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

Review 1.  Autoreactive B cells and epigenetics.

Authors:  Yves Renaudineau; Soizic Garaud; Christelle Le Dantec; Ruby Alonso-Ramirez; Capucine Daridon; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 2.  Innate B Cells: the Archetype of Protective Immune Cells.

Authors:  Alexis Grasseau; Marina Boudigou; Laëtitia Le Pottier; Nedra Chriti; Divi Cornec; Jacques-Olivier Pers; Yves Renaudineau; Sophie Hillion
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 3.  The Innate Part of the Adaptive Immune System.

Authors:  Sophie Hillion; Marina I Arleevskaya; Patrick Blanco; Anne Bordron; Wesley H Brooks; Jean Yves Cesbron; Srini Kaveri; Eric Vivier; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

4.  DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.

Authors:  Tinhinane Fali; Christelle Le Dantec; Yosra Thabet; Sandrine Jousse; Catherine Hanrotel; Pierre Youinou; Wesley H Brooks; Andras Perl; Yves Renaudineau
Journal:  Autoimmunity       Date:  2013-10-14       Impact factor: 2.815

5.  Exonal switch down-regulates the expression of CD5 on blasts of acute T cell leukaemia.

Authors:  A K Rai; A Singh; A Saxena; T Seth; V Raina; D K Mitra
Journal:  Clin Exp Immunol       Date:  2017-09-05       Impact factor: 4.330

Review 6.  Immune responses to endogenous retroelements: taking the bad with the good.

Authors:  George Kassiotis; Jonathan P Stoye
Journal:  Nat Rev Immunol       Date:  2016-04       Impact factor: 53.106

7.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

8.  Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis.

Authors:  Qinglong Jin; Yuki Moritoki; Ana Lleo; Koichi Tsuneyama; Pietro Invernizzi; Hitoshi Moritoki; Kentaro Kikuchi; Zhe-Xiong Lian; Gideon M Hirschfield; Aftab A Ansari; Ross L Coppel; M Eric Gershwin; Junqi Niu
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

9.  Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines.

Authors:  Sunil S Raikar; Lauren C Fleischer; Robert Moot; Andrew Fedanov; Na Yoon Paik; Kristopher A Knight; Christopher B Doering; H Trent Spencer
Journal:  Oncoimmunology       Date:  2017-12-26       Impact factor: 8.110

10.  Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.

Authors:  Diana Ahmetspahic; Kathrin Schwarte; Oliver Ambrée; Christian Bürger; Vladislava Falcone; Katharina Seiler; Mehrdad Rahbar Kooybaran; Laura Grosse; Fernand Roos; Julia Scheffer; Silke Jörgens; Katja Koelkebeck; Udo Dannlowski; Volker Arolt; Stefanie Scheu; Judith Alferink
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.